Vincerx Pharma Inc. (VINC) NASDAQ
$0.92 (0.03) (-2.95%)
Market Cap: $20.34M
As of 04/24/24 12:03 PM EDT. Market open.
Vincerx Pharma Inc. (VINC)
NASDAQ
$0.92
(0.03) (-2.95%)
Market Cap: $20.34M
As of 04/24/24 12:03 PM EDT. Market open.
Add to Portfolio
vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
7
URL
Address
.
PRICE CHART FOR VINCERX PHARMA INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.99
Previous Close
$0.95
Days Range
$0.87 - $0.99
52 week range
$0.61 - $9.37
Volume
302,545
Avg. Volume (30 days)
1,702,712
Market Cap
$20.34M
Dividend Yield
-
P/E
-
Shares Outstanding
21,413,389
Open
$0.99
Previous Close
$0.95
Days Range
$0.87 - $0.99
52 week range
$0.61 - $9.37
Volume
302,545
Avg. Volume (30 days)
1,702,712
Market Cap
$20.34M
Dividend Yield
-
P/E
-
Shares Outstanding
21,413,389
FINANCIAL STATEMENTS FOR VINCERX PHARMA INC
LOADING...
INSIDER TRANSACTIONS FOR VINCERX PHARMA INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Seelenberger Alexander A. | See Remarks | Aug 11, 2023 | Buy | $0.95 | 10,500 | 9,968 | 30,280 | Aug 14, 2023, 04:09 PM |
Hamdy Ahmed MD | See Remarks | Aug 09, 2023 | Buy | $0.95 | 16,900 | 15,994 | 90,660 | Aug 10, 2023, 06:28 PM |
Hamdy Ahmed MD | See Remarks | Aug 10, 2023 | Buy | $0.96 | 5,400 | 5,167 | 96,060 | Aug 10, 2023, 06:28 PM |
THOMAS TOM C | See Remarks | Aug 10, 2023 | Buy | $0.95 | 5,000 | 4,750 | 219,935 | Aug 10, 2023, 06:28 PM |
Izumi Raquel E. | See Remarks | Aug 10, 2023 | Buy | $0.93 | 3,440 | 3,199 | 85,214 | Aug 10, 2023, 06:27 PM |
Izumi Raquel E. | See Remarks | Aug 09, 2023 | Buy | $0.90 | 13,036 | 11,735 | 81,774 | Aug 10, 2023, 06:27 PM |
Izumi Raquel E. | See Remarks | Dec 14, 2022 | Buy | $0.88 | 28,738 | 25,427 | 68,738 | Dec 14, 2022, 09:22 PM |
Hamdy Ahmed MD | Chief Executive Officer | Dec 14, 2022 | Buy | $0.87 | 35,280 | 30,538 | 73,760 | Dec 14, 2022, 09:22 PM |
THOMAS TOM C | See Remarks | Dec 14, 2022 | Buy | $0.83 | 7,000 | 5,810 | 10,000 | Dec 14, 2022, 09:22 PM |
LOWE CHRISTOPHER P. | Director | Aug 25, 2022 | Buy | $1.65 | 11,600 | 19,139 | 40,000 | Aug 26, 2022, 04:06 PM |
LOWE CHRISTOPHER P. | Director | Aug 24, 2022 | Buy | $1.65 | 18,400 | 30,299 | 28,400 | Aug 26, 2022, 04:06 PM |
Izumi Raquel E. | See Remarks | Jun 27, 2022 | Buy | $1.41 | 40,000 | 56,312 | 40,000 | Jun 29, 2022, 04:05 PM |
Hamdy Ahmed MD | Chief Executive Officer | Jun 23, 2022 | Buy | $1.41 | 24,200 | 34,137 | 38,480 | Jun 27, 2022, 07:20 PM |
Bushnell Laura I. | Director | Jun 09, 2022 | Buy | $1.91 | 15,000 | 28,625 | 19,202 | Jun 13, 2022, 08:01 PM |
THOMAS TOM C | See Remarks | Dec 22, 2021 | Buy | $10.23 | 1,000 | 10,230 | 3,000 | Dec 27, 2021, 04:48 PM |
Hwang Sooin | Chief Business Officer | Dec 23, 2021 | Buy | $10.00 | 3,000 | 30,000 | 390,491 | Dec 27, 2021, 04:42 PM |
Bushnell Laura I. | Director | Dec 22, 2021 | Buy | $10.48 | 2,402 | 25,173 | 4,202 | Dec 27, 2021, 04:39 PM |
Seelenberger Alexander A. | Chief Financial Officer | Dec 22, 2021 | Buy | $10.34 | 2,417 | 24,988 | 12,493 | Dec 27, 2021, 04:34 PM |
Hamdy Ahmed MD | Chief Executive Officer | Dec 22, 2021 | Buy | $10.02 | 6,450 | 64,650 | 14,280 | Dec 27, 2021, 04:28 PM |
Izumi Raquel E. | See Remarks | Aug 04, 2021 | Buy | $11.96 | 1,000 | 11,960 | 1,000 | Aug 06, 2021, 04:45 PM |
Lee John H. | Director | Jun 29, 2021 | Buy | $12.72 | 799 | 10,159 | 799 | Jul 01, 2021, 06:52 PM |
McDonald Andrew I | Director | Jun 29, 2021 | Buy | $12.38 | 20,000 | 247,600 | 20,000 | Jul 01, 2021, 06:05 AM |
Hamdy Ahmed MD | Chief Executive Officer | Jun 29, 2021 | Buy | $12.77 | 7,830 | 99,989 | 7,830 | Jun 30, 2021, 07:02 PM |
Bushnell Laura I. | Director | Jun 30, 2021 | Buy | $12.94 | 1,800 | 23,297 | 1,800 | Jun 30, 2021, 07:02 PM |
Seelenberger Alexander A. | Chief Financial Officer | Jun 29, 2021 | Buy | $12.61 | 7,950 | 100,260 | 7,950 | Jun 30, 2021, 06:59 PM |
LOWE CHRISTOPHER P. | Director | Jun 30, 2021 | Buy | $12.66 | 3,600 | 45,576 | 10,000 | Jun 30, 2021, 06:59 PM |
LOWE CHRISTOPHER P. | Director | Jun 29, 2021 | Buy | $12.59 | 6,400 | 80,576 | 6,400 | Jun 30, 2021, 06:59 PM |
THOMAS TOM C | See Remarks | Jun 29, 2021 | Buy | $12.58 | 2,000 | 25,160 | 2,000 | Jun 30, 2021, 06:57 PM |
Hwang Sooin | Chief Business Officer | Jun 30, 2021 | Buy | $12.66 | 500 | 6,330 | 385,575 | Jun 30, 2021, 06:56 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Seelenberger Alexander A. | See Remarks | 08/11/2023 | 9,968 |
Hamdy Ahmed MD | See Remarks | 08/09/2023 | 15,994 |
Hamdy Ahmed MD | See Remarks | 08/10/2023 | 5,167 |
THOMAS TOM C | See Remarks | 08/10/2023 | 4,750 |
Izumi Raquel E. | See Remarks | 08/10/2023 | 3,199 |
Izumi Raquel E. | See Remarks | 08/09/2023 | 11,735 |
Izumi Raquel E. | See Remarks | 12/14/2022 | 25,427 |
Hamdy Ahmed MD | Chief Executive Officer | 12/14/2022 | 30,538 |
THOMAS TOM C | See Remarks | 12/14/2022 | 5,810 |
LOWE CHRISTOPHER P. | Director | 08/25/2022 | 19,139 |
LOWE CHRISTOPHER P. | Director | 08/24/2022 | 30,299 |
Izumi Raquel E. | See Remarks | 06/27/2022 | 56,312 |
Hamdy Ahmed MD | Chief Executive Officer | 06/23/2022 | 34,137 |
Bushnell Laura I. | Director | 06/09/2022 | 28,625 |
THOMAS TOM C | See Remarks | 12/22/2021 | 10,230 |
Hwang Sooin | Chief Business Officer | 12/23/2021 | 30,000 |
Bushnell Laura I. | Director | 12/22/2021 | 25,173 |
Seelenberger Alexander A. | Chief Financial Officer | 12/22/2021 | 24,988 |
Hamdy Ahmed MD | Chief Executive Officer | 12/22/2021 | 64,650 |
Izumi Raquel E. | See Remarks | 08/04/2021 | 11,960 |
Lee John H. | Director | 06/29/2021 | 10,159 |
McDonald Andrew I | Director | 06/29/2021 | 247,600 |
Hamdy Ahmed MD | Chief Executive Officer | 06/29/2021 | 99,989 |
Bushnell Laura I. | Director | 06/30/2021 | 23,297 |
Seelenberger Alexander A. | Chief Financial Officer | 06/29/2021 | 100,260 |
LOWE CHRISTOPHER P. | Director | 06/30/2021 | 45,576 |
LOWE CHRISTOPHER P. | Director | 06/29/2021 | 80,576 |
THOMAS TOM C | See Remarks | 06/29/2021 | 25,160 |
Hwang Sooin | Chief Business Officer | 06/30/2021 | 6,330 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VINCERX PHARMA INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 176,020 | 0.00032% | 32.45% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 154,031 | 0.00002% | No change | Other |
BLACKROCK INC. | 64,259 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR VINCERX PHARMA INC
STOCK BUYBACKS FOR VINCERX PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.13%
1Q
06/30/2023
0.47%
2Q
03/31/2023
0.87%
3Q
12/31/2022
1.10%
4Q
09/30/2022
1.38%
5Q
06/30/2022
1.80%
6Q
03/31/2022
2.28%
7Q
12/31/2021
24.44%
8Q
09/30/2021
20.79%
9Q
06/30/2021
30.72%
10Q
03/31/2021
55.61%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VINCERX PHARMA INC
LOADING...